Newfound cancer cell biology suggests which patients will respond to immunotherapy

byNYU Langone HealthCredit: Pixabay/CC0 Public DomainPatients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after rece

Updated on: January 13,2024

Newfound cancer cell biology suggests which patients will respond to immunotherapy

byNYU Langone HealthCredit: Pixabay/CC0 Public DomainPatients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after rece

Updated on:January 13,2024

Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

by European Organisation for Research and Treatment of CancerCumulative incidence rates of breast cancer and 95% confidence intervals in women with and without benign breast disease within year at ind

Updated on: February 03,2024

Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

by European Organisation for Research and Treatment of CancerCumulative incidence rates of breast cancer and 95% confidence intervals in women with and without benign breast disease within year at ind

Updated on:February 03,2024

Map of tumors' immune cell populations points to new targets for immunotherapy

by Kevin Jiang,Harvard Medical SchoolMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteThe recent emergence of immuno

Updated on: April 09,2024

Map of tumors' immune cell populations points to new targets for immunotherapy

by Kevin Jiang,Harvard Medical SchoolMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteThe recent emergence of immuno

Updated on:April 09,2024

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on: February 20,2024

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on:February 20,2024

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca

Updated on: February 18,2024

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca

Updated on:February 18,2024

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on: April 14,2024

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on:April 14,2024

Targeting cancer's hidden master regulators

by Columbia University Irving Medical CenterSchematic of the VIPER (A), OncoTarget (B), and OncoTreat (C) methodologies. G.E.S.: gene expression signature. MoR: mode of regulation—i.e., genes who

Updated on: April 14,2024

Targeting cancer's hidden master regulators

by Columbia University Irving Medical CenterSchematic of the VIPER (A), OncoTarget (B), and OncoTreat (C) methodologies. G.E.S.: gene expression signature. MoR: mode of regulation—i.e., genes who

Updated on:April 14,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on: January 04,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on:January 04,2024

Breast MRI effective at detecting cancer in dense breasts, finds study

byRadiological Society of North AmericaForest plots show the incremental cancer detection rate (CDR) per 1000 screenings per modality. (A) Studies with handheld US. (B) Studies with automated wh

Updated on: January 23,2024

Breast MRI effective at detecting cancer in dense breasts, finds study

byRadiological Society of North AmericaForest plots show the incremental cancer detection rate (CDR) per 1000 screenings per modality. (A) Studies with handheld US. (B) Studies with automated wh

Updated on:January 23,2024

Foreign-born women in U.S. less likely to have mammograms

(HealthDay)—Regardless of the percentage of lifetime spent in the United States, foreign-born women are less likely to ever have received a mammogram compared with U.S.-born women, according to the Oc

Updated on: April 23,2024

Foreign-born women in U.S. less likely to have mammograms

(HealthDay)—Regardless of the percentage of lifetime spent in the United States, foreign-born women are less likely to ever have received a mammogram compared with U.S.-born women, according to the Oc

Updated on:April 23,2024

Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism

by Higher Education PressScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHIn recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have b

Updated on: March 30,2024

Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism

by Higher Education PressScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHIn recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have b

Updated on:March 30,2024

Genetically modified virus combats prostate cancer

by FAPESPIn a study with mice, a gene therapy developed in Brazil kills cancer cells and avoids adverse side effects when combined with chemotherapy. Credit: Marcos Santos / USP ImagensResearcher

Updated on: April 01,2024

Genetically modified virus combats prostate cancer

by FAPESPIn a study with mice, a gene therapy developed in Brazil kills cancer cells and avoids adverse side effects when combined with chemotherapy. Credit: Marcos Santos / USP ImagensResearcher

Updated on:April 01,2024